What Does the Sale of Precigen Shares Worth $1.1 Million by the CFO Mean for Investors?

Focused on gene and cellular therapies, this biotech firm reported a notable insider sale amid a year of rapid share price gains.

CryptoAlerta — análise de criptomoedas e mercado em tempo real